These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention. Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD Am Heart J; 2003 Feb; 145(2):e6. PubMed ID: 12595861 [TBL] [Abstract][Full Text] [Related]
27. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone. Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210 [TBL] [Abstract][Full Text] [Related]
28. Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention. Day JR; Malik IS; Weerasinghe A; Poullis M; Nadra I; Haskard DO; Taylor KM; Landis RC Heart; 2004 Jul; 90(7):794-9. PubMed ID: 15201252 [TBL] [Abstract][Full Text] [Related]
29. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164 [TBL] [Abstract][Full Text] [Related]
30. Intravenous administration of the glycoprotein IIb-IIIa receptor antagonist 7E3 induces reperfusion of an acute thrombotic occlusion of the canine coronary artery. Shetler TJ; Bailey BD; Jakubowski JA; Jackson CV Thromb Res; 1998 Apr; 90(2):95-100. PubMed ID: 9684763 [TBL] [Abstract][Full Text] [Related]
31. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. Feldman DN; Wong SC; Bergman G; Minutello RM J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400 [TBL] [Abstract][Full Text] [Related]
33. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury. Bright JM; Dowers K; Powers BE Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634 [TBL] [Abstract][Full Text] [Related]
35. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. EPILOG Investigators N Engl J Med; 1997 Jun; 336(24):1689-96. PubMed ID: 9182212 [TBL] [Abstract][Full Text] [Related]
36. [Clinical safety using the thrombocyte aggregation inhibitor c7E3 in interventional cardiology in 520 patients]. Machnig T; Zahn R; Rustige J; Gödicke J; Marsalek P; Gulba D Z Kardiol; 1997 Dec; 86(12):975-81. PubMed ID: 9499495 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions. Huang TC; Jordan RE; Hantgan RR; Alevriadou BR Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127 [TBL] [Abstract][Full Text] [Related]
38. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Adgey AA Am Heart J; 1998 Apr; 135(4):S43-55. PubMed ID: 9539495 [TBL] [Abstract][Full Text] [Related]
39. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Bhatt DL; Topol EJ JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650 [TBL] [Abstract][Full Text] [Related]
40. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. EPISTENT Investigators Lancet; 1998 Jul; 352(9122):87-92. PubMed ID: 9672272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]